Liquid biopsy is set to disrupt the companion diagnostics market

The use of the liquid biopsy, mutation detection from circulating tumour DNA (ctDNA), has been an area of active research. Credit: Soonthorn Wongsaita / Shutterstock.



  • liquid biopsy